{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:16Z","timestamp":1786113016471,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["zefq-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.zefq.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:17:56Z","timestamp":1775179076000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201eKaukasisch\u201c in medizinischen Studien: Ethische, rechtliche und wissenschaftliche Perspektiven am Beispiel der ophthalmologischen Studie \u201eLow-dose AtropIne for Myopia Control in Children\u201c (AIM)"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-7420","authenticated-orcid":false,"given":"Hakan","family":"Kaymak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-8204","authenticated-orcid":false,"given":"Berthold","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.zefq.2026.02.003_b0005","unstructured":"World Medical Association. WMA Declaration of Geneva; 2024. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-geneva\/. [Accessed 1 August 2025]."},{"key":"10.1016\/j.zefq.2026.02.003_b0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2105\/AJPH.88.9.1303","article-title":"White, European, Western, Caucasian, or what? Inappropriate labeling in research on race, ethnicity, and health","volume":"88","author":"Bhopal","year":"1998","journal-title":"Am J Public Health"},{"key":"10.1016\/j.zefq.2026.02.003_b0015","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.289.20.2709","article-title":"Use of race and ethnicity in biomedical publication","volume":"289","author":"Kaplan","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.zefq.2026.02.003_b0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.zefq.2026.02.003_b0025","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.zefq.2026.02.003_b0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068822","article-title":"Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms","volume":"13","author":"Farassat","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.zefq.2026.02.003_b0035","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1056\/NEJMsb025007","article-title":"The importance of race and ethnic background in biomedical research and clinical practice","volume":"348","author":"Burchard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.zefq.2026.02.003_b0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ajhg.2024.03.003","article-title":"Guidance on use of race, ethnicity, and geographic origin as proxies for genetic ancestry groups in biomedical publications","volume":"111","author":"Feero","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.zefq.2026.02.003_b0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11229-024-04769-8","article-title":"Ethno-racial categorisations for biomedical studies: the fair selection of research participants and population stratification","volume":"204","author":"\u017buradzki","year":"2024","journal-title":"Synthese"},{"key":"10.1016\/j.zefq.2026.02.003_b0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11019-022-10122-y","article-title":"Reductionist methodology and the ambiguity of the categories of race and ethnicity in biomedical research: an exploratory study of recent evidence","volume":"26","author":"Malinowska","year":"2023","journal-title":"Med Health Care Philos"},{"key":"10.1016\/j.zefq.2026.02.003_b0055","doi-asserted-by":"crossref","first-page":"M20","DOI":"10.1167\/iovs.18-25957","article-title":"IMI \u2013 defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies","volume":"60","author":"Flitcroft","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.zefq.2026.02.003_b0060","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.ophtha.2020.01.054","article-title":"Increased time outdoors is followed by reversal of the long-term trend to reduced visual acuity in Taiwan primary school students","volume":"127","author":"Wu","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.zefq.2026.02.003_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.62.5.3","article-title":"IMI risk factors for myopia","volume":"62","author":"Morgan","year":"2021","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.zefq.2026.02.003_b0070","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archophthalmol.2009.303","article-title":"Increased prevalence of myopia in the United States between 1971\u20131972 and 1999\u20132004","volume":"127","author":"Vitale","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.zefq.2026.02.003_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100786","article-title":"Increased prevalence of myopia in the United States between 1971 and 1972 and 1999 and 2004\u2014a reappraisal","volume":"5","author":"Bullimore","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.zefq.2026.02.003_b0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.zefq.2026.02.003_b0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.zefq.2026.02.003_b0090","series-title":"De generis humani varietate nativa","author":"Blumenbach","year":"1795"},{"key":"10.1016\/j.zefq.2026.02.003_b0095","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40615-017-0458-6","article-title":"Overcoming the racial hierarchy: the history and medical consequences of \u201cCaucasian\u201d","volume":"5","author":"Rambachan","year":"2018","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.zefq.2026.02.003_b0100","first-page":"381","article-title":"The apportionment of human diversity","author":"Lewontin","year":"1972","journal-title":"Evol. Biol."},{"key":"10.1016\/j.zefq.2026.02.003_b0105","first-page":"2381","article-title":"Genetic structure of human populations","volume":"298","author":"Rosenberg","year":"2002","journal-title":"Science (1979)"},{"key":"10.1016\/j.zefq.2026.02.003_b0110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajpa.23882","article-title":"AAPA statement on race and racism","volume":"169","author":"Fuentes","year":"2019","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.zefq.2026.02.003_b0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/biuz.201970606","article-title":"Jenaer Erkl\u00e4rung \u2013 Das Konzept der Rasse ist das Ergebnis von Rassismus und nicht dessen Voraussetzung","volume":"49","author":"Fischer","year":"2019","journal-title":"Biol unserer Zeit"},{"key":"10.1016\/j.zefq.2026.02.003_b0120","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2105\/AJPH.2005.067108","article-title":"Stormy weather: race, gene expression, and the science of health disparities","volume":"95","author":"Krieger","year":"2005","journal-title":"Am J Public Health"},{"key":"10.1016\/j.zefq.2026.02.003_b0125","unstructured":"European Union. Verordnung (EU) Nr. 536\/2014 des Europ\u00e4ischen Parlaments und des Rates vom 16. April 2014 \u00fcber klinische Pr\u00fcfungen mit Humanarzneimitteln und zur Aufhebung der Richtlinie 2001\/20\/EG Text von Bedeutung f\u00fcr den EWR. Document 32014R0536 2022. https:\/\/eur-lex.europa.eu\/legal-content\/DE\/TXT\/?uri=CELEX%3A32014R0536. [Accessed 1 August 2025)."},{"key":"10.1016\/j.zefq.2026.02.003_b0130","unstructured":"Bundesministerium der Justiz und f\u00fcr Verbraucherschutz, Bundesamt f\u00fcr Justiz. Allgemeines Gleichbehandlungsgesetz 2006:1897\u2013910. https:\/\/www.gesetze-im-internet.de\/agg\/. [Accessed 1 August 2025]."},{"key":"10.1016\/j.zefq.2026.02.003_b0135","doi-asserted-by":"crossref","first-page":"M132","DOI":"10.1167\/iovs.18-25955","article-title":"IMI \u2013 clinical myopia control trials and instrumentation report","volume":"60","author":"Wolffsohn","year":"2019","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.zefq.2026.02.003_b0140","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s00103-022-03620-0","article-title":"Diskriminierungssensible Sprache in der Forschung zu Migration und Gesundheit \u2013 eine Handreichung","volume":"65","author":"Bilgic","year":"2022","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.zefq.2026.02.003_b0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.64.6.7","article-title":"IMI 2023 Digest","volume":"64","author":"Sankaridurg","year":"2023","journal-title":"Investig Opthalmol Vis Sci"}],"container-title":["Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1865921726000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1865921726000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:45:16Z","timestamp":1785948316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1865921726000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S1865921726000371"],"URL":"https:\/\/doi.org\/10.1016\/j.zefq.2026.02.003","relation":{},"ISSN":["1865-9217"],"issn-type":[{"value":"1865-9217","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201eKaukasisch\u201c in medizinischen Studien: Ethische, rechtliche und wissenschaftliche Perspektiven am Beispiel der ophthalmologischen Studie \u201eLow-dose AtropIne for Myopia Control in Children\u201c (AIM)","name":"articletitle","label":"Article Title"},{"value":"Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.zefq.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}